Xiling is an Associate Program Director currently working in Small Molecule Pharma Technical Regulatory (PTR) Department in Genentech, a member of the Roche group, South San Francisco, California, US. Xiling manages Genentech products at various development stages responsible for developing CMC regulatory strategies and leads CMC submissions for global clinical trial applications in US, Canada, Europe, Asia-Pac, and Latin-American countries. Xiling is also in charge of Roche small molecule PTR activities in Asia-Pacific region. Prior to join PTR, Xiling worked in Analytical Department in Genentech for six years as analytical lead responsible for analytical development of Erivedge® (Vismodegib®) from IND to NDA. Prior to join Genentech, Xiling worked in Boehringer Ingelheim Pharmaceutical Inc. (BIPI), Connecticut, US. During the five-year tenure in BIPI, Xiling worked as an analytical scientist and was one of the contributors to analytical development of Tipranavir ®. Xiling has Master of Science degree in Analytical Chemistry from Virginia Polytechnic Institute and State University under Professor Harold McNair and a Bachelor of Science degree in Chemistry from Beijing Normal University, Beijing, China.